LifeMD is trading at $2.13, down 5.12%, with the cause of the October 21 decline unclear.
- The available news search surfaced no clear company-specific catalyst.
- LifeMD’s October 20 announcement scheduled third-quarter results for November 9; it did not report results or guidance.
- Healthcare and major indices were higher, so broader market or sector weakness does not explain the drop.